HIVACAT

CONTENT

Check-ear cohort: a community and researchers collaboration for STIs screening in HIV negative MSM
BackgroundActive collaboration between affected communities and researchers is critical for developing appropriate strategies...
Comparative transcriptomics of extreme phenotypes of human HIV-1 infection and SIV infection in...
High levels of HIV-1 replication during the chronic phase of infection usually correlate with rapid progression to severe...
A Therapeutic Dendritic Cell-Based Vaccine for HIV-1 Infection
Journal of Infectious Diseases 2011:0 (15 February)
A double-blinded, controlled study of vaccination of untreated patients with chronic human immunodeficiency virus type 1 (HIV-1)...
Viral Adaptation to Immune Selection Pressure by HLA Class I Restricted CTL Responses Targeting...
J. Exp. Med
xCD8+ cytotoxic T lymphocyte (CTL)–mediated immune responses to HIV contribute to viral control in vivo. Epitopes encoded...

2nd Antivirals Congress: From Bench to Bedside
11.11.12
11-13 November 2012 | Cambridge, MA, USA The key objectives of this congress are: To provide a state-of-the-art report for scientists,...
21.05.12 - 21.05.12
Seminar on HIV: Treatment, prevention and eradication

The Fundación Valenciana de Estudios Avanzados organises a seminar on the treatment, the prevention and the eradication of the...

More information
21.05.12 - 22.05.12
RIBORED 2012 Valencia: V Reunión de la Red Temática Española de RNA
Venue
Campus de la Universidad Politécnica de Valencia (UPV)
Salón de actos de la Ciudad Politécnica de la...

More information

CUTHIVAC Cutaneous HIV Vaccination
Financing entity: European Comission
Participant entities: Universite Pierre et Marie Curie, University of Regensburg, FIT Biotech Oy Ltd, CHARITE, St George’s University of London, MRC Medical Research Council, IMPACTA, Centre National de la Recherche Scientifique, INSERM, Instituto Nacional de Saúde, GENEART AG, NOVAMEN
Research Supervisor(s): Christian Brander

IrsiCaixa